Specifically, experimental approaches, such as immunohistochemistry, quantitative PCR, or functional assays using prostate cancer and neural cell co-culture systems, could validate the biological relevance of hub genes identified in our study, such as SFRP4, ESR1, and others, in the context of perineural invasion. The gene discussed is SFRP4; the disease is Familial prostate cancer.